Customer Perspectives on the Supply Chain after COVID-19

This document is a report that discusses the impact of the COVID-19 pandemic on the pharmaceutical supply chain. It outlines the challenges faced by companies, including the need for greater visibility and transparency, as well as the importance of real-time data to navigate disruptions. The report highlights the shift in supply chain models as organizations reassess their operations and accelerate digital transformation initiatives. It describes how companies are adapting to a remote workforce and the necessity for agile responses to supply shortages and logistical challenges. The document emphasizes the critical need for coordination and communication among internal teams and external partners, particularly as many companies transition to cloud-based solutions. It also addresses the importance of maintaining regulatory processes under pressure and the shared responsibility of securing the supply chain across various global markets. The report concludes with a call for collaboration and innovation to ensure patient safety and supply chain reliability during these unprecedented times.